Last Updated：2025/11/25
The new anti-gov-antibody showed promising activity against ovarian tumors in early clinical trials.
See correct answer
The new anti-gov-antibody showed promising activity against ovarian tumors in early clinical trials.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
